Suppr超能文献

前循环急性缺血性卒中血栓切除术区域网络组织:时机、安全性和有效性

A Regional Network Organization for Thrombectomy for Acute Ischemic Stroke in the Anterior Circulation; Timing, Safety, and Effectiveness.

作者信息

Mourand Isabelle, Malissart Pauline, Dargazanli Cyril, Nogue Erika, Bouly Stephane, Gaillard Nicolas, Boukriche Yassine, Corti Lucas, Picot Marie-Christine, Beaufils Olivier, Chbicheb Mohamed, Sablot Denis, Bonafe Alain, Costalat Vincent, Arquizan Caroline

机构信息

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France.

Department of Neuroradiology, University Hospital Center, Montpellier, France.

出版信息

J Stroke Cerebrovasc Dis. 2019 Feb;28(2):259-266. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.051. Epub 2018 Nov 12.

Abstract

BACKGROUND

Mechanical thrombectomy (MT) in association with intravenous thrombolysis is recommended for treatment of acute ischemic stroke (AIS), with large vessel occlusion (LVO) in the anterior circulation. Because MT is only available in comprehensive stroke centers (CSC), the challenge of stroke organization is to ensure equitable access to the fastest endovascular suite. Our aim was to evaluate the feasibility, efficacy, and safety of MT in patients initially managed in 1 CSC (mothership), compared with patients first managed in primary stroke center (PSC), and then transferred to the CSC for MT (drip-and-ship).

METHODS

We retrospectively analyzed 179 consecutive patients (93 in the mothership group and 86 in the drip-and-ship group), with AIS secondary to LVO in the anterior cerebral circulation and a clinical-radiological mismatch (NIHSS ≥ 8 and DWI-ASPECT score ≥5), up to 6 hours after symptoms onset. We evaluated 3-month functional modified Rankin scale (mRS), periprocedural time management, mortality, and symptomatic intracranial haemorrhage (sICH).

RESULTS

Despite significant longer process time in the drip-and-ship group, mRS ≤ 2 at 3 months (39.8% versus 44.1%, P = .562), Thrombolysis in cerebral infarction 2b-3 (85% versus 78%, P = .256), and sICH (7.0% versus 9.7%, P = .515) were similar in both group regardless of baseline clinical or radiological characteristics. After multivariate logistic regression, the predictive factors for favorable outcome were age (odds ratio [OR] = 1.32, P < .001), initial NIHSS (OR  = 1.59, P = .010), absence of diabetes (OR = 3.35, P = .075), and the delay magnetic resonance imagining-puncture (OR  = 1.16, P = .048).

CONCLUSIONS

Our study showed encouraging results from a regional protocol of MT comparing patients transferred from PSC or brought directly in CSC.

摘要

背景

对于伴有前循环大血管闭塞(LVO)的急性缺血性卒中(AIS)患者,推荐采用机械取栓(MT)联合静脉溶栓治疗。由于MT仅在综合卒中中心(CSC)开展,卒中组织面临的挑战是确保公平获得最快的血管内治疗设备。我们的目的是评估在1个CSC(母船医院)初始治疗的患者与首先在初级卒中中心(PSC)治疗,然后转至CSC进行MT治疗(滴注转运)的患者中MT的可行性、有效性和安全性。

方法

我们回顾性分析了179例连续患者(母船医院组93例,滴注转运组86例),这些患者均为前脑循环LVO继发的AIS,且存在临床-影像学不匹配(美国国立卫生研究院卒中量表[NIHSS]≥8分且弥散加权成像-脑缺血半暗带评估量表[DWI-ASPECT]评分≥5分),症状发作后6小时内就诊。我们评估了3个月时的改良Rankin量表(mRS)功能评分、围手术期时间管理、死亡率和症状性颅内出血(sICH)。

结果

尽管滴注转运组的治疗时间明显更长,但无论基线临床或影像学特征如何,两组在3个月时mRS≤2的比例(39.8%对44.1%,P = 0.562)、脑梗死溶栓2b-3级比例(85%对78%,P = 0.256)和sICH比例(7.0%对9.7%,P = 0.515)相似。多因素逻辑回归分析后,良好预后的预测因素为年龄(比值比[OR]=1.32,P<0.001)、初始NIHSS评分(OR = 1.59,P = 编者注:原文此处有误,应是P = 0.010)、无糖尿病(OR = 3.35,P = 0.075)以及磁共振成像-穿刺延迟时间(OR = 1.16,P = 0.048)。

结论

我们的研究显示,在比较从PSC转来或直接送至CSC的患者的MT区域方案中,取得了令人鼓舞的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验